TP53 and gastric cancer: Among NHW GC patients, PI3K and TGF-Beta pathway alterations were significantly associated with worse overall survival (p < 0.0001 and p = 0.016, respectively), whereas no significant survival differences were observed for TP53, WNT, or RTK/RAS alterations.